Call: 954-398-4474

Navigating Pregnancy with Type 1 Diabetes: The Role of Dexcom’s G7

Navigating Pregnancy with Type 1 Diabetes

Introduction: Embracing the Challenges of Pregnancy with Type 1 Diabetes

Every year, over 130 million women give birth to pregnancy with type 1 diabetes (T1D), the journey involves heightened risks and challenges. However, successfully managing the phases before and after pregnancy is entirely possible—with the right game plan, an exceptional team, and the right tools.

Tip: Fill out this form to check if you or a friend qualify for Continuous Glucose Monitors.

The Vital Role of Blood Sugar Management during Pregnancy

Whether in the planning phase or newly pregnant, effective blood sugar management stands as a top priority for Pregnancy with type 1 diabetes. The target range for blood sugar levels during pregnancy is more stringent than the standard 70-180mg/dL, aiming to minimize complications like preeclampsia, premature delivery, or miscarriages.

Empowering Diabetes Management: The CGM Advantage

Continuous Glucose Monitors (CGMs) emerge as invaluable tools in navigating diabetes during pregnancy. These small wearable devices track blood glucose levels in real-time, providing insights that aid in thoughtful decision-making around food, exercise, and medication, including insulin.

Must Read CGMs in noncritical care hospitals optimizes glycemic control

Dexcom’s G7: Revolutionizing CGM Use in Pregnancy

Beyond Type 1 delved into the latest research on Dexcom’s G7 CGM, speaking with Jake Leach, Dexcom’s Chief Operating Officer. The G7, Dexcom’s smallest CGM to date, offers significant advancements:

  • 60% smaller than the G6, featuring an all-in-one sensor and transmitter.
  • Reduced warm-up period from two hours to just 30 minutes.
  • Introduction of a 12-hour grace period for seamless sensor replacement.

The Breakthrough Pregnancy Study

Dexcom recently presented groundbreaking results from its pregnancy study at the 59th Annual European Association for the Study of Diabetes meeting in Hamburg. This study, conducted in the US, showcased the G7’s performance in pregnant women, marking a pivotal moment for CGM application in pregnancy.

Also, Read about A Comprehensive Guide for Veterans with Diabetes

Informed Diabetes Management Plan: CGM Benefits during Pregnancy

Jake Leach highlighted the potential of CGMs in enhancing communication between expectant mothers and their physicians. With better insights into diabetes management plans, adjustments throughout pregnancy become more informed and personalized.

Access and Affordability: Making Dexcom G7 Accessible

The Dexcom G7, approved for pregnancy use, brings hope with its accessibility. Jake Leach emphasized the importance of physicians incorporating CGMs into treatment plans for expectant mothers. He envisions continued access to CGMs during pregnancy, positioning it as the standard of care for diabetes management.

Read Guide about Wegovy Dosage Guide: The Best Way For Weight Loss

Personalized Diabetes Management: A CGM for Every Pregnancy

Acknowledging the uniqueness of each diabetes case and every pregnancy, having tools like the Dexcom G7 becomes indispensable. Understanding glucose levels and their fluctuations during pregnancy is empowered by the insights provided by a CGM.

Conclusion: Dexcom G7 – A Vital Addition to the Pregnancy Toolkit

For those expecting or already pregnant, the recommendation is clear—engage with your doctor about integrating Dexcom’s G7 into your pregnancy toolkit. As Dexcom actively partners with Beyond Type 1, this insight into their latest research underscores the commitment to advancing diabetes care for expectant mothers with T1D.